CETRELIMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Investigational

Investigational

Approval Year

Name

Type

Language

IMMUNOGLOBULIN G4, ANTI-(PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL JNJ-63723283 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL JNJ-63723283 .KAPPA.-CHAIN, DIMER

Preferred Name

English

CETRELIMAB

Official Name

English

cetrelimab [INN]

Common Name

English

CETRELIMAB [USAN]

Common Name

English

Cetrelimab [WHO-DD]

Common Name

English

IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS PROGRAMMED CELL DEATH PROTEIN 1 (ANTIGEN CD279)) HUMAN MONOCLONAL ANTIBODY .GAMMA.4 HEAVY CHAIN (1-450) (HOMO SAPIENS VH (IGHV1-69*01 (99%) (IGHD)-IGHJ4*01 (93%)) (8.8.16) (1-123) -HOMO SAPIENS IGHG4*01 (HINGE(

Systematic Name

English

JNJ63723283

Code

English

JNJ-63723283

Code

English

Code System Code Type Description

USAN

FG-99

Created by admin on Tue Apr 01 23:23:20 GMT 2025 , Edited by admin on Tue Apr 01 23:23:20 GMT 2025

PRIMARY

NCI_THESAURUS

C129448

Created by admin on Tue Apr 01 23:23:20 GMT 2025 , Edited by admin on Tue Apr 01 23:23:20 GMT 2025

PRIMARY

FDA UNII

LYK98WP91F

Created by admin on Tue Apr 01 23:23:20 GMT 2025 , Edited by admin on Tue Apr 01 23:23:20 GMT 2025

PRIMARY

CAS

2050478-92-5

Created by admin on Tue Apr 01 23:23:20 GMT 2025 , Edited by admin on Tue Apr 01 23:23:20 GMT 2025

PRIMARY

SMS_ID

100000178251

Created by admin on Tue Apr 01 23:23:20 GMT 2025 , Edited by admin on Tue Apr 01 23:23:20 GMT 2025

PRIMARY

INN

10757

Created by admin on Tue Apr 01 23:23:20 GMT 2025 , Edited by admin on Tue Apr 01 23:23:20 GMT 2025

PRIMARY

DRUG BANK

DB15421

Created by admin on Tue Apr 01 23:23:20 GMT 2025 , Edited by admin on Tue Apr 01 23:23:20 GMT 2025

PRIMARY

ACTIVE MOIETY


					LYK98WP91F